Compare HIMS & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HIMS | PSO |
|---|---|---|
| Founded | 2017 | 1844 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.4B |
| IPO Year | N/A | 2000 |
| Metric | HIMS | PSO |
|---|---|---|
| Price | $37.08 | $13.95 |
| Analyst Decision | Hold | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $44.90 | N/A |
| AVG Volume (30 Days) | ★ 17.6M | 785.2K |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.34% |
| EPS Growth | 20.76 | ★ 31.65 |
| EPS | 0.54 | ★ 0.90 |
| Revenue | $2,210,958,000.00 | ★ $4,822,578,436.00 |
| Revenue This Year | $62.21 | $2.34 |
| Revenue Next Year | $18.79 | $5.09 |
| P/E Ratio | $69.31 | ★ $15.57 |
| Revenue Growth | ★ 78.02 | N/A |
| 52 Week Low | $23.97 | $12.85 |
| 52 Week High | $72.98 | $17.90 |
| Indicator | HIMS | PSO |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 64.07 |
| Support Level | $36.65 | $13.03 |
| Resistance Level | $40.74 | $14.06 |
| Average True Range (ATR) | 1.83 | 0.13 |
| MACD | 0.47 | 0.14 |
| Stochastic Oscillator | 31.52 | 89.64 |
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.